ref_name,rx_name,iso_name,section,assay_name,potency_type,potency,cumulative_count,potency_upper_limit,potency_lower_limit,potency_unit,date_added
Ref22,Casirivimab + Imdevimab,S:614G,Figure 4,Pseudovirus (HIV),IC50,3.6,1,5000,1,ng/ml,2022-01-01
Ref22,Casirivimab + Imdevimab,S:406W,Figure 4,Pseudovirus (HIV),IC50,336.1,1,5000,1,ng/ml,2022-01-01
